Alchemy Ascent

Scheme Rating

IME Scheme Rating

The Scheme does not meet our selection criteria at this time

Investment Option: We would advise investors to wait for the scheme to mature (5 years+), before deploying capital into this strategy.

IME Strategy Rating

Quant-Algorithm based Approach: Alchemy Ascent follows a quant-algorithm approach towards stock selection. This is a departure from Alchemy’s past focus as a fundamental active stock picker, and the value of their quant algorithm is yet to be proven.

PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).

IME View on Alchemy Ascent

Type: Flexi Cap | Quant | AUM (464.9 cr) | Inc Date (03 Sep 2019)

Alchemy Ascent- Investment Strategy

Quant based strategy

Alchemy Ascent follows a quant-based investment strategy, the takes an unbiased approach towards each stock by allowing data to filter out emotions of greed and fear. Various parameters are fed into the model including quality filters, negative marking for unfavorable BS ratios, financial/fundamental parameters, and more, all of which are combined to get an individual score for each stock that changes on a daily basis.

Trailing Performance

1yr 3yr 5yr Since Inception
Alchemy Ascent 64.6 25.4 21.9
S&P BSE 500 TRI 39.5 19.5 21.6
Alpha over Broad Mkt BM 25.1 5.9 0.3
Nifty 500 38.4 18.1
Alpha over Category BM 26.2 7.3

Performance as of: 28-Feb-23 | Inception Date: 03-Sep-19

Fund Managers

Vikas Kumar | 4-star rated FM

Fund Manager | 23 yrs Experience

Past Experience: Dalal & Broacha, Reliance Capital

Vikas has over 19 years of equity market experience, in the fields of equity research, private client fund management and strategy in the sell-side. He specialises in data-based quantitative algorithms.

Fee Structure

Fee StructureFee
Fixed Fee Structure2.5
Variable Fee Structures1.5% fixed + 15% above 10% hurdle
Exit Fees1yr(1%)


AMC: Alchemy PMS (click link for detailed AMC review)

Not a top recommendation (at this time) due to weak recent performance: Backed by solid founders, a CIO that is a co-founder and well-respected investor and a long track record of identifying interesting bottom-up investment opportunities, Alchemy has all the ingredients for a successful PMS business. However, their performance has been very sub-par in recent years, and it is this underperformance that is the primary reason behind Alchemy not being a 5 or 4-star rated PMS.

AMC Rating

3 of 5 stars

AMC Pedigree

4 of 5 stars

AMC Size

4 of 5 stars

Team Pedigree

5 of 5 stars

Inv Philosophy

3 of 5 stars


3 of 5 stars

Get substantially greater insights by connecting with us!

Details shared on the public website, are only a short snapshot of the more detailed analysis that resides in our Proprietary Research Management Solution (RMS) – A proprietary cloud-based tool, that ensures that the unbiased research insights of our central research team are shared directly with investors.

Our RMS allows us to operate with a level of transparency, ethics & consistency of insights, that is unparrarelled in the industry. Our RM’s will help showcase the PMS/AIF options that are the most suited for your unique requirements.

Download Sample RMS Reports: AMC View | Scheme Comparison

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.